Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vabysmo
Pharma
RemeGen, Roche, Hengrui and more—Fierce Pharma Asia
Pfizer and RemeGen's HER2 ADC posted a phase 3 win. Roche plans to build a new Chinese plant. Hengrui gears up for a Hong Kong IPO. And more.
Angus Liu
May 16, 2025 10:20am
Roche puts up nearly $300M to expand manufacturing in China
May 9, 2025 10:06am
Regeneron's Eylea franchise stumbles on several fronts in Q1
Apr 29, 2025 2:50pm
FDA denies Regeneron's bid for dosage flexibility on Eylea
Apr 21, 2025 8:45am
FDA gives thumbs-up to Roche's Susvimo as treatment for DME
Feb 4, 2025 3:15pm
UK watchdog reaffirms Bayer's claims of misleading Roche promos
Jan 31, 2025 11:20am
